Device Maker Poised for Growth Amid Weight Loss Drug Evolution
**Executive Brief:** Drugmakers Novo Nordisk and Eli Lilly are competing in the GLP-1 weight loss market, with Novo Nordisk’s pill version of Ozempic intensifying the rivalry. Meanwhile, Intuitive Surgical continues to grow in the surgical










